Nalo Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Nalo Therapeutics Inc.
- Target Recruit Count
- 258
- Registration Number
- NCT05514496
- Locations
- 🇺🇸
City of Hope - Seacliff, Huntington Beach, California, United States
🇺🇸City of Hope Comprehensive Cancer Center - Duarte, Duarte, California, United States
🇺🇸City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States
News
No news found